Clinical Trials Browser

Phase 1 × Lymphoma, T-Cell × pembrolizumab × Clear all

NCT03240211 2025-08-26

Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL

Phase 1 Active not recruiting

Lymphoma, T-Cell